Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
Eric L. Sievers(Seagen (United States)), Matthias Theobald(Johannes Gutenberg University Mainz), Jacques J. M. van Dongen(Universidad de Salamanca), Edward A. Stadtmauer(University of Pennsylvania), Chatchada Karanes(Erasmus MC Cancer Institute), Bob Löwenberg(Unknown), Irwin D. Bernstein(Fred Hutch Cancer Center), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elihu H. Estey(University of Washington), Michael R. Loken(Unknown), John M. Bennett(University of Rochester Medical Center), Richard A. Larson(Urbana University), Matthew L. Sherman, Mark S. Berger(Erasmus MC Cancer Institute), Hervé Dombret(University of London Institute in Paris), Catharine B. Eten(Erasmus MC Cancer Institute)
Cited by 898